Literature DB >> 32857276

Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study.

Byung-Woo Yoo1, Sang-Won Lee1, Jason Jungsik Song1, Yong-Beom Park1, Seung Min Jung2,3.   

Abstract

OBJECTIVE: To investigate the clinical and imaging features predicting the histopathological diagnosis of immunoglobulin G4 (IgG4)-related disease (IgG4RD) in patients with suspected IgG4RD on computed tomography (CT).
METHODS: We retrospectively reviewed the medical records of 178 patients with CT findings suspicious of IgG4RD from January 2015 to December 2017. Patients who underwent tissue biopsy were included to evaluate the association between patient characteristics and histopathological diagnosis of IgG4RD. The histopathological diagnosis was classified into IgG4RD and non-IgG4RD. Clinical, laboratory, and imaging features were compared between patients with IgG4RD and non-IgG4RD, and logistic regression analysis was performed to identify the predictors for histopathologically confirmed IgG4RD.
RESULTS: Of the 103 patients with histopathologically proven diseases, 46 and 57 patients were classified as IgG4RD and non-IgG4RD, respectively. The median age was 64 years; 65% of patients were male. There were significant differences in sex (P = 0.035), fever (P = 0.039), serum IgG4 level (P < 0.001), renal involvement (P = 0.036), lacrimal or salivary glands involvement (P = 0.050), swelling pattern on CT (P = 0.001), and positron emission tomography (PET)-CT findings (P < 0.001) between patients with IgG4RD and non-IgG4RD. Multivariate analysis revealed elevated IgG4 level > 135 mg/dL (odds ratio [OR] = 5.418, P < 0.001), kidney involvement (OR = 6.170, P = 0.044), and the swelling feature on CT (OR = 4.301, P = 0.012) to be independent factors for histopathological diagnosis of IgG4RD.
CONCLUSION: This study suggests that elevated IgG4 level, renal involvement, and swelling pattern on CT are associated with histopathological diagnosis of IgG4RD. The clinical and imaging features might help to decide further evaluation in patients with clinically suspected IgG4RD. Key Points • Computed tomography (CT) is not sufficient to discriminate between IgG4-related disease (IgG4RD) and non-IgG4RD conditions. • Histopathological diagnosis of IgG4RD is associated with elevated IgG4 level, renal involvement, and swelling pattern on CT. • Positron emission tomography-CT may be a useful diagnostic tool in patients with clinically suspected IgG4RD. >.

Entities:  

Keywords:  Biopsy; Computed tomography; Immunoglobulin G4; Immunoglobulin G4-related disease; Kidney; Swelling

Mesh:

Substances:

Year:  2020        PMID: 32857276     DOI: 10.1007/s10067-020-05366-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Tadashi Yoshino; Shigeo Nakamura; Shigeyuki Kawa; Hideaki Hamano; Terumi Kamisawa; Toru Shimosegawa; Akira Shimatsu; Seiji Nakamura; Tetsuhide Ito; Kenji Notohara; Takayuki Sumida; Yoshiya Tanaka; Tsuneyo Mimori; Tsutomu Chiba; Michiaki Mishima; Toshifumi Hibi; Hirohito Tsubouchi; Kazuo Inui; Hirotaka Ohara
Journal:  Mod Rheumatol       Date:  2012-01-05       Impact factor: 3.023

Review 2.  Extrapancreatic findings of IgG4-related disease.

Authors:  T J Tan; Y L Ng; D Tan; W S Fong; A S C Low
Journal:  Clin Radiol       Date:  2013-11-26       Impact factor: 2.350

Review 3.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

Review 4.  Cross-sectional pictorial review of IgG4-related disease.

Authors:  Darya Kurowecki; Michael N Patlas; Ehsan A Haider; Abdullah Alabousi
Journal:  Br J Radiol       Date:  2019-07-29       Impact factor: 3.039

Review 5.  Atypical manifestations of IgG4-related sclerosing disease in the abdomen: imaging findings and pathologic correlations.

Authors:  Jin Hee Kim; Jae Ho Byun; Seung Soo Lee; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

6.  Systemic IgG4-related sclerosing disease: spectrum of imaging findings and differential diagnosis.

Authors:  Marius Horger; Hans-Georg Lamprecht; Roland Bares; Daniel Spira; Marc Schmalzing; Claus Detlef Claussen; Patrick Adam
Journal:  AJR Am J Roentgenol       Date:  2012-09       Impact factor: 3.959

7.  Spectrum of IgG4-related disease on multi-detector CT: a 5-year study of a single medical center data.

Authors:  Yonglan He; Xuechao Du; Ning Ding; Zhuo Li; Weixun Zhou; Bo Chen; Zhengyu Jin; Hao Sun; Liang Zhu; Huadan Xue
Journal:  Abdom Imaging       Date:  2015-10

8.  Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis.

Authors:  Yasunari Fujinaga; Masumi Kadoya; Shigeyuki Kawa; Hideaki Hamano; Kazuhiko Ueda; Mitsuhiro Momose; Satoshi Kawakami; Sachie Yamazaki; Tomoko Hatta; Yukiko Sugiyama
Journal:  Eur J Radiol       Date:  2009-07-05       Impact factor: 3.528

9.  A new clinicopathological entity of IgG4-related autoimmune disease.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi; Yoshinobu Eishi; Morio Koike; Kouji Tsuruta; Atsutake Okamoto; Naoto Egawa; Hitoshi Nakajima
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

Review 10.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.

Authors:  Zachary S Wallace; Ray P Naden; Suresh Chari; Hyon K Choi; Emanuel Della-Torre; Jean-Francois Dicaire; Phillip A Hart; Dai Inoue; Mitsuhiro Kawano; Arezou Khosroshahi; Marco Lanzillotta; Kazuichi Okazaki; Cory A Perugino; Amita Sharma; Takako Saeki; Nicolas Schleinitz; Naoki Takahashi; Hisanori Umehara; Yoh Zen; John H Stone
Journal:  Ann Rheum Dis       Date:  2019-12-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.